Dhirisha Bhatt

1.0k total citations · 1 hit paper
9 papers, 695 citations indexed

About

Dhirisha Bhatt is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Dhirisha Bhatt has authored 9 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Neurology and 2 papers in Epidemiology. Recurrent topics in Dhirisha Bhatt's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Dhirisha Bhatt is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Dhirisha Bhatt collaborates with scholars based in United States, India and Nepal. Dhirisha Bhatt's co-authors include Reshma Golamari, Rohit Jain, Nitasa Sahu, Devyani Ramgobin, Ricci Kalayanamitra, Brendan McClafferty, Zainab Shahid, Chander Shekher Aggarwal, Kirk D. Jones and Ravi Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Journal of the American Geriatrics Society.

In The Last Decade

Dhirisha Bhatt

8 papers receiving 679 citations

Hit Papers

COVID ‐19 and Older Adults: What We Know 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dhirisha Bhatt United States 5 221 211 165 151 134 9 695
Zainab Shahid United States 5 222 1.0× 208 1.0× 169 1.0× 151 1.0× 135 1.0× 16 725
Ricci Kalayanamitra United States 5 222 1.0× 208 1.0× 169 1.0× 151 1.0× 141 1.1× 12 719
Brendan McClafferty United States 5 231 1.0× 244 1.2× 188 1.1× 152 1.0× 139 1.0× 8 747
Chander Shekher Aggarwal United States 6 228 1.0× 237 1.1× 187 1.1× 148 1.0× 152 1.1× 7 761
Devyani Ramgobin United States 8 231 1.0× 243 1.2× 188 1.1× 152 1.0× 156 1.2× 12 832
Nitasa Sahu United States 7 247 1.1× 229 1.1× 178 1.1× 172 1.1× 143 1.1× 19 786
Reshma Golamari United States 12 265 1.2× 285 1.4× 218 1.3× 175 1.2× 172 1.3× 36 988
Stephanie Manson Brown United States 7 143 0.6× 144 0.7× 68 0.4× 97 0.6× 179 1.3× 13 545
Claudia Nau United States 14 99 0.4× 261 1.2× 130 0.8× 79 0.5× 134 1.0× 34 698
Sulmaz Ghahramani Iran 14 303 1.4× 209 1.0× 117 0.7× 57 0.4× 97 0.7× 63 984

Countries citing papers authored by Dhirisha Bhatt

Since Specialization
Citations

This map shows the geographic impact of Dhirisha Bhatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhirisha Bhatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhirisha Bhatt more than expected).

Fields of papers citing papers by Dhirisha Bhatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhirisha Bhatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhirisha Bhatt. The network helps show where Dhirisha Bhatt may publish in the future.

Co-authorship network of co-authors of Dhirisha Bhatt

This figure shows the co-authorship network connecting the top 25 collaborators of Dhirisha Bhatt. A scholar is included among the top collaborators of Dhirisha Bhatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dhirisha Bhatt. Dhirisha Bhatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wall, Barry M., et al.. (2023). Lupus Nephritis Complicated by Atypical Hemolytic Uremic Syndrome and Heterozygous Deletion in CFHR1-CFHR3 Successfully Treated with Ravulizumab. Journal of the American Society of Nephrology. 34(11S). 277–277.
2.
Shah, Neal, et al.. (2021). Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient. BMJ Case Reports. 14(7). e243692–e243692. 3 indexed citations
3.
Kalayanamitra, Ricci, Zainab Shahid, Justin Roy, et al.. (2021). DRESS is a Mess: A Case of Cross Reactivity Between Lacosamide and Lamotrigine.. PubMed. 74(7). 324–328. 4 indexed citations
4.
Golamari, Reshma, Nitasa Sahu, Rama Vunnam, et al.. (2021). Rare enough ? Cardiac Device‐related pocket Infection due to Mycobacterium fortuitum. SHILAP Revista de lepidopterología. 9(3). 1566–1570. 1 indexed citations
5.
McClafferty, Brendan, Ricci Kalayanamitra, Zainab Shahid, et al.. (2020). Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients. Journal of Clinical Neuroscience. 79. 241–245. 18 indexed citations
6.
Ramgobin, Devyani, Ricci Kalayanamitra, Zainab Shahid, et al.. (2020). The Economic Implications of COVID-19 in the United States.. PubMed. 73(5). 218–222. 4 indexed citations
7.
Cai, Alice, Brendan McClafferty, Devyani Ramgobin, et al.. (2020). COVID-19: Catastrophic Cause of Acute Lung Injury.. PubMed. 73(6). 252–260. 15 indexed citations
8.
Shahid, Zainab, Ricci Kalayanamitra, Brendan McClafferty, et al.. (2020). COVID ‐19 and Older Adults: What We Know. Journal of the American Geriatrics Society. 68(5). 926–929. 649 indexed citations breakdown →
9.
Smolderen, Kim G., Lei Ye, Eyal Cohen, et al.. (2010). One-year costs associated with cardiovascular disease in Canada: Insights from the REACH registry. Canadian Journal of Cardiology. 26. 297–305. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026